Specifically, we observed a differential expression pattern in GBM-tissues (SSTR2 > SSTR1 > SSTR5 > SSTR4 > SSTR3) compared to the control-tissues (SSTR1 > SSTR2 > SSTR3 > SSTR4 > SSTR5). This evidence concerns the gene SSTR5 and glioblastoma.